(Q40008936)

16 September 2017

title

Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease (English)

1 reference

16 September 2017

0 references

8

Raymund A C Roos

1 reference

16 September 2017

Caroline K Jurgens

1

1 reference

16 September 2017

Lotte van de Wiel

2

1 reference

16 September 2017

Ad C G M van Es

3

1 reference

16 September 2017

Yvette M Grimbergen

4

1 reference

16 September 2017

Marie-Noëlle W Witjes-Ané

5

1 reference

16 September 2017

Jeroen van der Grond

6

1 reference

16 September 2017

Huub A M Middelkoop

7

1 reference

16 September 2017

publication date

1 November 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

255

1 reference

16 September 2017

issue

11

1 reference

16 September 2017

page(s)

1785-1791

1 reference

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0050-4

Basal ganglia volume and proximity to onset in presymptomatic Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0050-4

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0050-4

Onset and rate of striatal atrophy in preclinical Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0050-4

Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0050-4

A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0050-4

Profile of cognitive progression in early Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0050-4

A Standardized Memory Scale for Clinical Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0050-4

Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study

21 January 2018

1 reference

12 December 2020

Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study

1 reference

12 December 2020

Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease

1 reference

12 December 2020

Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study

1 reference

12 December 2020

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

1 reference

12 December 2020

Behavioural complaints in participants who underwent predictive testing for Huntington's disease

1 reference

12 December 2020

Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.

1 reference

12 December 2020

Brain structure in preclinical Huntington's disease.

1 reference

12 December 2020

Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers

1 reference

12 December 2020

Psychomotor, executive, and memory function in preclinical Huntington's disease

1 reference

12 December 2020

The distribution of structural neuropathology in pre-clinical Huntington's disease

1 reference

12 December 2020

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition

1 reference

12 December 2020

Preparing for preventive clinical trials: the Predict-HD study

1 reference

12 December 2020

1 reference

12 December 2020

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

1 reference

12 December 2020

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

1 reference

12 December 2020

Brain imaging and cognitive dysfunctions in Huntington's disease

1 reference

12 December 2020

Neuropsychological and neuroradiological correlates in Huntington's disease

1 reference

12 December 2020

ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group

1 reference

12 December 2020

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease

1 reference

12 December 2020

When does Huntington's disease begin?

1 reference

12 December 2020

Unified Huntington's disease rating scale: Reliability and consistency

1 reference

12 December 2020

Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis

1 reference

12 December 2020

Verbal episodic memory declines prior to diagnosis in Huntington's disease

1 reference

12 December 2020

Longitudinal personality changes among presymptomatic Huntington disease gene carriers.

1 reference

12 December 2020

10.1007/S00415-008-0050-4

Identifiers

DOI

1 reference

16 September 2017

1 reference